Clinical Trials and Studies

Please find below a list of active, ongoing, non-Phase 1 studies sponsored by Endo. For studies that are required to be listed on www.clinicaltrials.gov, you can access additional detail about individual studies by clicking on the link or navigating to clinicaltrials.gov and search using the identifier number listed. For inquiries about our ongoing clinical trials, please contact us at clinicalsite.inquiries@endo.com.


Study ID

Study Description

Intervention

Study Phase/Type

Recruitment Status* / ClinicalTrials.gov Identifier (if applicable)
EN3835-201 A Phase 2, randomized, double-blind, placebo-controlled study of EN3835 in the treatment of edematous fibrosclerotic panniculopathy Collagenase clostridium histolyticum Phase IIb Active, not recruiting
New Window
NCT02724644
EN3835-202 A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy Collagenase clostridium histolyticum Phase 2 Enrolling by invitation
New Window
NCT02942160

*Recruitment Status


Definition

Not yet recruiting

participants are not yet being recruited
Recruiting

participants are currently being recruited
Enrolling by invitation

participants are being (or will be) selected from a predetermined population
Active, not recruiting study is ongoing (i.e., patients are being treated or examined), but participants are not currently being recruited or enrolled
Completed the study has concluded normally; participants are no longer being examined or treated (i.e., last patient's last visit has occurred)
Suspended

recruiting or enrolling participants has halted prematurely but potentially will resume
Terminated recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
Withdrawn study halted prematurely, prior to enrollment of first participant

 


 newWindow_gray.png By clicking on the link(s) on this page you will leave the Endo.com website and move to an external website(s) independently operated and not managed by Endo Pharmaceuticals. Because Endo Pharmaceuticals does not control the content of the website(s) you are about to visit, and due to its constantly changing nature, we cannot be responsible for its content, accuracy, practices, or standards.

US/RD/CORP/2014/00002a 5/2014

About Endo

Close

Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.

Visit Endo.com